A detailed history of Asset Dedication, LLC transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Asset Dedication, LLC holds 1,671 shares of FLGT stock, worth $37,330. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,671
Holding current value
$37,330
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$19.09 - $22.57 $31,899 - $37,714
1,671 New
1,671 $32,000
Q4 2021

Jan 21, 2022

SELL
$77.3 - $105.0 $10,512 - $14,280
-136 Closed
0 $0
Q2 2021

Jul 21, 2021

BUY
$66.8 - $100.45 $9,084 - $13,661
136 New
136 $13,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $676M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Asset Dedication, LLC Portfolio

Follow Asset Dedication, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Dedication, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Asset Dedication, LLC with notifications on news.